Becker’s asked C-suite executives from hospitals and health systems across the U.S. to share the areas they’re focusing on for 2025.
Category: Becker’s Hospital Review
Bird flu: 6 developments to know heading into 2025
Federal officials have maintained that the nation’s bird flu outbreak does not pose an immediate threat to public health, but infectious disease experts say recent developments indicate the H5N1 virus’ spread is widening — and with it, the risks it pos…
Georgia health system names chief development officer
Valdosta-based South Georgia Medical Center has promoted Hilary Gibbs to vice president of support services and chief development officer.
Georgia health system names chief development officer
Valdosta-based South Georgia Medical Center has promoted Hilary Gibbs to vice president of support services and chief development officer.
President-elect Trump names 2 Justice Department picks: 7 things to know
President-elect Donald Trump has nominated Aaron Reitz to serve as head of the Justice Department Office of Legal Policy and Chad Mizelle as chief of staff at the Justice Department, according to two Dec. 21 Truth Social posts.
10 headwinds for health systems in 2025
Healthcare executives are preparing for 2025, a year likely filled with profound challenges and big opportunities.
Texas hospital furloughs 25% of workforce
Mid Coast Medical Center-Central in Llano, Texas, is taking several measures to reduce costs and maintain operations at the facility.
IU Health children's hospital names new president
Indianapolis-based Riley Children’s Health, part of Indianapolis-based Indiana University Health, has named David Biggerstaff president, effective Feb. 2.
Physicians slam Congress for failure to offset Medicare pay cuts
Congress has signed a pared-down funding bill to prevent a government shutdown but failed to pass measures in a previously proposed bipartisan package that would have offset the 2.83% Medicare pay cut physicians face in 2025.
FDA approves Zepbound for obstructive sleep apnea
Zepbound, Eli Lilly’s weight loss medication, became the first FDA-approved drug for obstructive sleep apnea Dec. 20.
